Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Inari Medical Inc (NARI) stock saw a modest uptick, ending the day at $79.74 which represents a slight increase of $0.28 or 0.35% from the prior close of $79.46. The stock opened at $79.54 and touched ...

Medical and surgical device makers are riding on a surge in demand as more people in the U.S., particularly older Americans, ...

“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an ...

Danielle Antalffy; Analyst; UBS Equities Michael Polark; Analyst; Wolfe Research ...

Q4 2024 Earnings Call Transcript January 28, 2025 Stryker Corporation beats earnings expectations. Reported EPS is $4.01, expectations were $3.87. Operator: Welcome to the Fourth Quarter 2024 Stryker ...

Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Full Year Results “We delivered another year of double-digit organic sales growth ...

Inari Medical (TASE:PMCN) Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the $4.68 billion medical device company.

The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its ...

Stryker Corporation's innovation and market leadership justify a premium. See why SYK stock is a solid hold with long-term ...